Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein Inc. (symbol: HSIC) is the world's largest provider of healthcare products and services to office-based dental, animal health, and medical practitioners. As a Fortune 500® company and a member of the S&P 500® and NASDAQ 100® indexes, Henry Schein employs more than 18,000 team members and serves over one million customers globally. The company's offerings extend to dental laboratories, government and institutional healthcare clinics, and other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, offering a comprehensive selection of more than 100,000 branded products and private-label products, as well as over 150,000 additional products available as special-order items.
The company is organized into two main segments: Healthcare Distribution and Technology & Value-Added Services. The Healthcare Distribution segment focuses on distributing consumable products, small equipment, and laboratory products. The Technology & Value-Added Services segment provides innovative software solutions and other technology services designed to help healthcare practitioners run their practices more efficiently and deliver high-quality care.
In recent years, Henry Schein has achieved significant milestones, including expanding its product range and forming strategic partnerships to enhance its service offerings. The company continues to innovate with exclusive technology solutions aimed at improving practice management and patient care.
Henry Schein (NASDAQ: HSIC) has signed a cooperative contract with OMNIA Partners to enhance procurement access for K-12, higher education, and healthcare sectors. This agreement includes a master contract with the University of California, facilitating medical supply distribution to eligible public agencies. The offerings include point-of-care diagnostic testing, PPE, and various medical products. The contract aims to streamline procurement, increase savings, and improve health services accessibility for students and staff.
Henry Schein (NASDAQ: HSIC) has donated over
Henry Schein has appointed Scott Serota, former President and CEO of Blue Cross Blue Shield Association, to its Board of Directors effective immediately. Serota, who expanded BCBSA's membership from 65 million to over 100 million, is expected to contribute his healthcare expertise to advance the company's strategic goals. Meanwhile, Barry Alperin will retire from the Board in May, adhering to the director resignation policy upon reaching 80 years of age. This change aims to bolster leadership and a focus on public health challenges.
Henry Schein Orthodontics has launched Studio Pro™ 4.0, an advanced web-based treatment planning software for Reveal® Clear Aligners. This new platform, integrated with the DDX® Case Management Portal, enables providers to customize treatment plans with over 25 new features, enhancing user experience for practitioners of all skill levels. Phil Prentice, President of Henry Schein’s Orthodontics Group, emphasized the software's role in simplifying workflows. The software aims to improve patient communication and treatment control, marking a significant advancement in orthodontic technology.
Henry Schein, Inc. (NASDAQ: HSIC) showcases its innovative products and solutions at the 2021 Greater New York Dental Meeting, aiming to improve practice efficiency for oral health professionals. Attendees can explore product demonstrations from leading brands and a new loyalty program, Henry Schein Thrive Rewards. Educational courses, including one on Revenue Cycle Management, are also featured. Notable solutions include practice management software, patient communication tools, and advanced dental technology, enhancing patient experiences and practice workflows.
Henry Schein, Inc. (Nasdaq: HSIC), a leading provider of health care solutions, announced its participation in three virtual investor conferences in December 2021. The events include the Piper Sandler 33rd Annual Virtual Healthcare Conference on December 1, Nasdaq's 44th Virtual Investor Conference at 11:30 a.m. ET on December 2, and the Evercore ISI 4th Annual HealthCONx Virtual Conference at 1:00 p.m. ET on the same day. Live webcasts of the two latter presentations will be accessible to registered attendees.
Henry Schein Cares Foundation, in collaboration with the UPS Foundation, announced the third phase of the "Wearing is Caring" campaign aimed at promoting health equity and access to COVID-19 vaccines. Launched in October 2020, the initiative addresses healthcare disparities in underserved communities. A CDC report indicates that only 56% of Americans are fully vaccinated, with lower rates among minority groups. The campaign emphasizes the role of primary care physicians in vaccination decisions, with 88% of survey respondents citing their doctor’s advice as influential.
Zimbis has launched a partnership with Southern Anesthesia & Surgical (SAS) to enhance medication and supply management for dental professionals. This collaboration introduces an order integration system that streamlines inventory management, allowing automatic population of product reorder information on SAS's website. By improving operational efficiencies, this partnership aims to enable dental surgeons to focus more on patient care. Both companies anticipate that this integration will significantly benefit the dental surgery market.